EFFICACY, SAFETY, AND TOLERABILITY OF ORAL SEMAGLUTIDE VERSUS PLACEBO ADDED TO INSULIN WITH OR WITHOUT METFORMIN IN PATIENTS WITH TYPE 2 DIABETES: THE PIONEER 8 TRIAL